The Latest Cardiac and Vascular News
SOUTHLAKE, Texas & MARSEILLE, France–(BUSINESS WIRE)–Rapid Medical™, a leading developer of active endovascular devices, announces that its DRIVEWIRE™ 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America during a limited commercial launch beginning earlier this year. The company also announced receipt of CE Mark under the […]
Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter’s Trackability, Navigation, and Overall Performance in Stroke Procedures MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly…
Advanced 3D model recreates pathological flow conditions to study underlying cerebrovascular disease mechanisms BUSAN, South Korea, Aug. 19, 2025 /PRNewswire/ — Cerebrovascular diseases, including atherosclerosis and stroke, remain a major global health concern. A common feature of these…
SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, filed a patent infringement lawsuit against Balt USA, LLC (Balt) alleging infringement of five U.S. patents held by Route 92 Medical that […]
TACOMA, Wash., July 31, 2025 /PRNewswire/ — Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast Track designation to RNS60, its lead…
NEW YORK, July 24, 2025 /PRNewswire/ — GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 Clinical Trials of its lead drug Nelonemdaz, has been approved by MFDS – South Korea’s…
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]
Trial met primary endpoints of similar rates of serious adverse events (SAEs) and fewer deaths observed with RNS60 versus placebo Statistically significant reduction in infarct growth (brain tissue loss) – a secondary endpoint – in patients treated with RNS60 adjunct to endovascular…
Late-Breaking Data Presented at Society of NeuroInterventional Surgery Annual Meeting Demonstrate Excellent Reperfusion Results and Unparalleled Safety with the Zoom System for Ischemic Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced a late-breaking abstract with data from the Imperative Trial evaluating aspiration with the Zoom System in stroke patients with M2 […]
Real-World U.S. Physician Preference Data1 Demonstrates the SOFIA™ 88 Catheter’s Trackability, Atraumatic Design, and Overall Performance in Stroke Procedures NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned…
